Viewing Study NCT06503770



Ignite Creation Date: 2024-10-26 @ 3:35 PM
Last Modification Date: 2024-10-26 @ 3:35 PM
Study NCT ID: NCT06503770
Status: RECRUITING
Last Update Posted: None
First Post: 2024-07-08

Brief Title: A Retrospective Chart Review Study of Patients With Chronic Lung Allograft Dysfunction-Bronchiolitis Obliterans Syndrome CLAD-BOS Post Lung Transplantation
Sponsor: None
Organization: None

Study Overview

Official Title: A Retrospective Chart Review Study of Patients With Chronic Lung Allograft Dysfunction-Bronchiolitis Obliterans Syndrome CLAD-BOS Post Lung Transplantation
Status: RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The aim of this study is to describe the forced expiratory volume in 1 second FEV1 decline and natural disease evolution in patients affected by CLAD-BOS after lung transplantation and receiving an immunosuppressive therapy as standard of care
Detailed Description: This is a retrospective multinational multicenter chart review study of adult patients with clinically diagnosed CLAD-BOS after lung transplantation All data will be retrospectively collected from patient records starting from lung transplantation date through last date of available data and as such no interventions will be applied as part of this study

The observational period for each patient will be from lung transplant date until last date of data available or death whichever occurs earlier and will include the following time periods

Diagnosis window 01 January 2013 through most recent data available

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None